(In millions) | ||||||
---|---|---|---|---|---|---|
Year Ended June 30, | 2010 | 2009 | 2008 | |||
Common stock and paid-in capital | ||||||
Balance, beginning of period | $ | 62,382 | $ | 62,849 | $ | 60,557 |
Common stock issued | 2,311 | 567 | 3,504 | |||
Common stock repurchased | (3,113) | (2,611) | (3,022) | |||
Stock-based compensation expense | 1,891 | 1,708 | 1,479 | |||
Stock-based compensation income tax benefits (deficiencies) | (647) | (128) | 253 | |||
Other, net | 32 | (3) | 78 | |||
Balance, end of period | 62,856 | 62,382 | 62,849 | |||
Retained deficit | ||||||
Balance, beginning of period | (22,824) | (26,563) | (29,460) | |||
Cumulative effect of a change in accounting principle relating to uncertain tax positions | 0 | 0 | (395) | |||
Cumulative effect of a change in accounting principle relating to costs of certain compensated absences | 0 | 0 | (17) | |||
Net income | 18,760 | 14,569 | 17,681 | |||
Other comprehensive income: | ||||||
Net unrealized gains on derivatives | 27 | 302 | 18 | |||
Net unrealized gains (losses) on investments | 265 | (233) | (653) | |||
Translation adjustments and other | (206) | (240) | 121 | |||
Comprehensive income | 18,846 | 14,398 | 17,167 | |||
Common stock cash dividends | (4,547) | (4,620) | (4,084) | |||
Common stock repurchased | (8,156) | (6,039) | (9,774) | |||
Balance, end of period | (16,681) | (22,824) | (26,563) | |||
Total stockholders’ equity | $ | 46,175 | $ | 39,558 | $ | 36,286 |
See accompanying notes.